Evidence map›Paper›PMID 29344351›Full record

ArticleAntimicrobial resistance and infection control2018

Endemic carbapenem-nonsusceptible

Yulia Rosa Saharman, Anis Karuniawati, Rudyanto Sedono, Dita Aditianingsih, Pratiwi Sudarmono, Wil H F Goessens, Corné H W Klaassen, Henri A Verbrugh, Juliëtte A Severin

Registry-linked trialAbstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05293483 (The Impact of Hospital Care for COVID-19 on the Prevalence of Multidrug-resistant Microorganisms Among Patients Compared to Non-COVID-19 Hospital Care in Limited-resource Hospitals in Indonesia), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05293483 unknown statusnot on this mapstarted 2022, after this paper: background citation

The Impact of Hospital Care for COVID-19 on the Prevalence of Multidrug-resistant Microorganisms Among Patients Compared to Non-COVID-19 Hospital Care in Limited-resource Hospitals in Indonesia

Typeobservational_patient_registrySponsorErasmus Medical CenterRan2022 to 2023Enrolled1,110ConditionsAntibiotic Resistant Infection, COVID-19
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Genetic profiling of multidrug-resistantMicrobiology spectrum · 2025
    Article
  2. Article
  3. Review
  4. Molecular Epidemiology of Clinical Carbapenem-ResistantTropical medicine and infectious disease · 2022
    Article
  5. Article
  6. Review
  7. Molecular Characterization of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Observational
  10. Review
  11. Infection and drug resistance · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yulia Rosa Saharman1Department of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia/ Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Anis Karuniawati1Department of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia/ Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Rudyanto Sedono3Critical Care Division, Department of Anesthesia and Intensive Care, Faculty of Medicine, Universitas Indonesia / Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Dita Aditianingsih3Critical Care Division, Department of Anesthesia and Intensive Care, Faculty of Medicine, Universitas Indonesia / Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Pratiwi Sudarmono1Department of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia/ Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Wil H F Goessens2Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.
Corné H W Klaassen2Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.
Henri A Verbrugh2Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.
Juliëtte A Severin2Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carbapenem-nonsusceptible Methods: A prospective observational study was performed on the intensive care units (ICUs) of the national referral hospital in Jakarta-Indonesia, in 2013 and 2014. All consecutive adult patients admitted and hospitalized for >48 h in ICUs were included. Basic and clinical data at admission were recorded. Carbapenem-nonsusceptible Results: Of 412 included patients, 69 (16.7%) carried carbapenem-nonsusceptible Conclusions: Carbapenem-nonsusceptible Trial registration: The study was retrospectively registered at www.trialregister.nl (No:5541). Candidate number: 23,527, NTR number: NTR5541, Date registered NTR: 22nd December 2015.

Indexed as

Intensive Care UnitsMolecular EpidemiologyReferral and ConsultationAcinetobacter baumanniiAcinetobacter calcoaceticusAcinetobacter InfectionsAdultAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDNA, BacterialDrug Resistance, BacterialFemaleHealth PersonnelHumansAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsDNA, BacterialAcinetobacter baumannii-calcoaceticus complexAntimicrobial resistanceCarbapenemaseCarbapenemsIndonesiaIntensive care unit

Identifiers

PMID29344351
PMCPMC5767053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.